Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Healthcare Medical Devices
Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.


TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > 👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(12)
•••
Comment by jopatcloon Nov 21, 2024 10:44am
49 Views
Post# 36323739

RE:RE:👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀

RE:RE:👀 The Mayo Clinic has purchased a VMS+3.2 model 📍🚀Good comment Interesting $$$

@marcge81 @Rocket67 Why would anyone be interested in competing with VPT if their product can't sell?
 
2
 
@marcge81 Seeing as VPT just sold a unit to Mayo, doesn't that validate that VMS is a much needed medical device, that other hospitals will want to purchase?
 
6
 
@cardinal yes
 
7
 
@Lplanz @marcge81 ****SARCASM WARNING**** The reason Mayo bought is the same reason Duke and other leading institutions bought: They like to waste their precious time on useless gadgets. We all know how little hospitals value their time.
 
3
 
@cardinal The CEO of Novadaq told me investors were threatening to kill him. years and years of slugging it out. Then they made some key sales and more sales followed. within a year they sold for a billion canadian. Medtech is goofy and the candian market is a retail joke
 
4
 
@cardinal MAyo paid 50k US
 
3
 
@marcge81 @cardinal the USA OTCBB is even worse than the TSX. What market do you recommend they up-list to? How about the AMEX?
 
1
 
@cardinal down the road if they havent been bought they will be on NAsdaq
 
1
Yajne wrote: This is indeed very encouraging. I am puzzled though, why didn't they include Mayo clinic in the NR? IMO just the mention of Mayo Clinic and their initial purchase would cause a market reaction. So, does anybody know why Mayo not mentioned in NR? I only see it in Dr. George Adams letter....


@marcge81 @Rocket67 Why would anyone be interested in competing with VPT if their product can't sell?
 
2
 
@marcge81 Seeing as VPT just sold a unit to Mayo, doesn't that validate that VMS is a much needed medical device, that other hospitals will want to purchase?
 
6
 
@cardinal yes
 
7
 
@Lplanz @marcge81 ****SARCASM WARNING**** The reason Mayo bought is the same reason Duke and other leading institutions bought: They like to waste their precious time on useless gadgets. We all know how little hospitals value their time.
 
3
 
@cardinal The CEO of Novadaq told me investors were threatening to kill him. years and years of slugging it out. Then they made some key sales and more sales followed. within a year they sold for a billion canadian. Medtech is goofy and the candian market is a retail joke
 
4
 
@cardinal MAyo paid 50k US
 
3
 
@marcge81 @cardinal the USA OTCBB is even worse than the TSX. What market do you recommend they up-list to? How about the AMEX?
 
1
 
@cardinal down the road if they havent been bought they will be on NAsdaq
 
1
 

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities